CLASS II ONGOING Drug recall · Reported 4 Feb 2026 · FDA Enforcement Report
methylprednisolone tablets, USP Dosepak, 4 mg recalled by Greenstone
Greenstone is recalling methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing, distributed nationwide in the US. The recall was initiated on 15 Jan 2026 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0299-2026
- FDA event ID
- 98278
- Recalling firm
- Greenstone, Peapack, NJ
- Brand
- Methylprednisolone
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 15 Jan 2026
- FDA classified
- 28 Jan 2026
- Reported
- 4 Feb 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
Timeline
| 15 Jan 2026 | Recall initiated by company | |
| 28 Jan 2026 | Classified by FDA | +13 days |
| 4 Feb 2026 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
Product as listed by the FDA
methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2
Where it was distributed
Nationwide within the United States
Questions about this recall
Why was it recalled?
Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
Which lots are affected?
Lot # LG7675, Exp. Date Nov 2026
Where was it sold?
Nationwide within the United States
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Greenstone
All 7| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Venlafaxine HCl Extended-Release Capsules, 150 mg Unit of Use recalled | Greenstone | Packaging Defects | Nationwide |
| Drug | CLASS III | Glipizide XL (glipizide) extended release tablets, 5 mg recalled | Greenstone | Potency & Assay | Nationwide |
| Drug | CLASS II | sertraline HCl tablets, 25 mg recalled by Greenstone | Greenstone | Other | Nationwide |
| Drug | CLASS II | Nifedipine, extended-release tablets, 90mg recalled by Greenstone | Greenstone | Packaging Defects | Nationwide |
| Drug | CLASS II | Spironolactone tablets, USP 50 mg recalled by Greenstone | Greenstone | Potency & Assay | Nationwide |
Other Methylprednisolone recalls
All 69| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | MethylPREDNISolone Acetate Injectable Suspension recalledMethylprednisolone Acetate | Sagent Pharmaceuticals | Particulate Matter | Nationwide |
| Drug | CLASS II | Methylprednisolone acetate Injectable Suspension recalled by Eugia USMethylprednisolone Acetate | Eugia US | Potency & Assay | 4 states |
| Drug | CLASS III | Methylprednisolone Acetate Injectable Suspension recalled | Amneal Pharmaceuticals of New York | Packaging Defects | Nationwide |
| Drug | CLASS II | Methylprednisolone 12MG IN NS Syringe, steroid recalled | Sentara Infusion Services | Sterility | Nationwide |
| Drug | CLASS II | MethyLPREDNISolone Acetate Injectable Suspension recalled | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |